CFO SpotlightsCareers of chief financial officers, from the filings. Records as of October 28, 2026

  1. CFO Spotlights
  2. Profiles
  3. Michael G. Knell

Profile

Michael G. Knell

Interim Chief Financial Officer, Corporate Senior Vice President, Chief Accounting Officer (duly authorized officer and Principal Financial and Accounting Officer), Charles River Laboratories

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Michael G. Knell signed the annual report of Charles River Laboratories as Interim Chief Financial Officer, Corporate Senior Vice President, Chief Accounting Officer (duly authorized officer and Principal Financial and Accounting Officer); the report was filed on February 18, 2026, the most recent filing in the record that ties Michael G. Knell to the seat.1

Seats

The seat in the record

CompanyTitle as filedStandingFilings
Charles River Laboratories (CRL)
Services-Commercial Physical & Biological Research
Interim Chief Financial Officer, Corporate Senior Vice President, Chief Accounting Officer (duly authorized officer and Principal Financial and Accounting Officer)In the seat1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

  1. February 18, 202610-K filed

    Michael G. Knell signed the annual report of Charles River Laboratories on Form 10-K as Interim Chief Financial Officer, Corporate Senior Vice President, Chief Accounting Officer (duly authorized officer and Principal Financial and Accounting Officer), filed February 18, 2026.

    /s/ MICHAEL G. KNELL Michael G. Knell Interim Chief Financial Officer, Corporate Senior Vice President, Chief Accounting Officer (duly authorized officer and Principal Financial and Accounting Officer)

    [1] Annual report on Form 10-K by Charles River Laboratories, filed with the SEC on February 18, 2026. Read the filing. The record at CFO Tribune.

Sources

Sources

  1. Annual report on Form 10-K, Charles River Laboratories. U.S. Securities and Exchange Commission, EDGAR, filed February 18, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Michael G. Knell wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.